Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126835191 | 12683519 | 1 | I | 20160403 | 0 | 20160824 | 20160824 | DIR | 71.00 | YR | M | N | 69.10000 | KG | 20160817 | N | PH | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126835191 | 12683519 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Oral | MG BID PO | Y | D | 0 | BID | |||||||
| 126835191 | 12683519 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | D | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126835191 | 12683519 | 1 | Pain |
| 126835191 | 12683519 | 2 | Cerebrovascular accident prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126835191 | 12683519 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126835191 | 12683519 | Anaemia | |
| 126835191 | 12683519 | Gastric ulcer haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126835191 | 12683519 | 1 | 20160301 | 20160403 | 0 | |
| 126835191 | 12683519 | 2 | 20160301 | 20160403 | 0 |